AI generated summary of Pubmed citation/abstract with PMID 38091642

https://pubmed.ncbi.nlm.nih.gov/38091642

Cytogenetic analysis remains a crucial component in the diagnosis, prognosis, and management of myelodysplastic neoplasms, with new guidelines from the GFCH reflecting recent changes in WHO and ICC classifications and the increasing importance of molecular features.